跳至主要内容
临床试验/NCT03436576
NCT03436576Unknown3 期

Comparison of Autologous Serum 20% and Autologous Serum 50% for the Treatment of Severe Dry Eye

Pontificia Universidad Catolica de Chile1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2018年9月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
20
试验地点
1
主要终点
Change in Ocular Surface Disease Index (OSDI) Score

研究概览

简要总结

The purpose of this study is to compare the effects of autologous serum 20% and autologous serum 50% for the treatment of Severe Dry Eye Syndrome

详细描述

To determine the difference between autologous serum 20% vs 50%, in terms of improvement of symptoms, improvement of ocular surface parameters and acceptable tolerability in patients with severe dry eye syndrome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Man/woman ≥ 18 years old, able to freely give consent to participate in the study
  • At least 1 of the following tests altered:
  • Ocular Surface Disease Index (OSDI) Test symptoms > 32
  • BUT ≤5 seconds
  • Oxford staining ≥ 3
  • Schirmer Test without anesthesia ≤ 5 mm

排除标准

  • Sensitivity or known intolerance to any of the products used in the study
  • Contraindication of venipuncture
  • Story of ocular infections within the 6 previous months to study inclusion
  • Any active ocular pathology other than Dry Eye Syndrome
  • Use of contact lenses in the 3 previous months to study inclusion
  • No pregnant or breastfeeding women is allowed to participate in the study. Childbearing potential women must use contraceptive means during the whole study.
  • Participation in another clinical trial in the last 30 days before study inclusion

研究组 & 干预措施

Autologous Serum 20%

Active Comparator

Treatment with Autologous Serum 20% for 2 months

干预措施: Autologous Serum 20% (Drug)

Autologous Serum 50%

Active Comparator

Treatment with Autologous Serum 50% for 2 months

干预措施: Autologous Serum 50% (Drug)

结局指标

主要结局

Change in Ocular Surface Disease Index (OSDI) Score

时间窗: 1 month

The Ocular Surface Disease Index (OSDI) is a 12-item questionnaire designed to provide a rapid assessment of the symptoms of ocular irritation consistent with dry eye disease and their impact on vision-related functioning. The overall OSDI score defines the ocular surface as normal (0-12 points) or as having mild (13-22 points), moderate (23-32 points), or severe (33-100 points) disease.

次要结局

  • Change in Ocular Surface Disease Index (OSDI) Score(1 week, 2 months)
  • Change in Schirmer I(1 week, 1 month, 2 months)
  • Change in Tear Break Up Time (TBUT)(1 week, 1 month, 2 months)
  • Change in Oxford Staining score(1 week, 1 month, 2 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验